The US Food and Drug Administration (FDA) recently granted orphan drug approval for Chrysoeriol, a cannabis-based drug used to treat acute myeloid leukaemia, which was developed by Jamaican scientist Dr Henry Lowe. Lowe founded Medicanja Ltd — described as “Jamaica’s first medical cannabis company” — in 2013. Its distinguished board of directors includes two former prime ministers and a former governor general. The US Orphan Drug Act gives special status to a drug or biological product to treat a rare disease or condition upon the request of a sponsor. Under the act, Lowe will qualify for some development incentives, including tax credits for some clinical testing. After presenting his research findings at the 2017 Global Health Catalyst Summit at Harvard Medical School in April 2017, Lowe made the announcement at a July 12 press conference at his wellness resort in Kingston, which both Prime Minister Andrew Holness and science and…

Contact Info

P.O BOX 219
Shop 12B
CGS Building
8 Lady Musgrave Road
Kingston 5, Jamaica W.I

(876) 977-2512 | (876) 470-7919 (Digi)
Fax: (876) 970-9227

Mon - Fri: 8:00 am - 5:00 pm
Saturday & Sunday: Closed

Copyright 2017 JMDA ©  All Rights Reserved

Web Design: Franco Pencle